Fresenius Medical Care AG (BVMF:FMSC34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 57.81B -29.0% |
| Revenue (ttm) | 116.44B -0.7% |
| Net Income | 5.68B +52.8% |
| EPS | 19.81 +56.3% |
| Shares Out | n/a |
| PE Ratio | 10.17 |
| Forward PE | 28.76 |
| Dividend | 3.07 (2.55%) |
| Ex-Dividend Date | May 22, 2025 |
| Volume | n/a |
| Average Volume | 71 |
| Open | 120.24 |
| Previous Close | 120.24 |
| Day's Range | 120.24 - 120.24 |
| 52-Week Range | 117.30 - 165.95 |
| Beta | 0.82 |
| RSI | 45.11 |
| Earnings Date | May 5, 2026 |
About Fresenius Medical Care AG
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospital... [Read more]
Financial Performance
In 2025, Fresenius Medical Care AG's revenue was 19.63 billion, an increase of 1.51% compared to the previous year's 19.34 billion. Earnings were 978.37 million, an increase of 81.88%.
Financial numbers in EUR Financial StatementsNews
Fresenius Medical price target lowered to EUR 40 from EUR 42 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Fresenius Medical (FMS) to EUR 40 from EUR 42 and keeps a Hold rating on the shares. Published first on TheFly –
Fresenius Medical price target lowered to EUR 33 from EUR 34 at Morgan Stanley
Morgan Stanley analyst Aisyah Noor lowered the firm’s price target on Fresenius Medical (FMS) to EUR 33 from EUR 34 and keeps an Underweight rating on the shares. Published first
Q1 2026 Fresenius Medical Care AG Earnings Call Transcript
Q1 2026 Fresenius Medical Care AG Earnings Call Transcript
Relative Strength Alert For Fresenius Medical Care
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a tec...
EQS-CMS: Fresenius Medical Care AG : Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Post-admission Duties announcement: Fresenius Medical Care AG / Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] Fresenius Medical Care ...
Fresenius Medical Care AG Earnings Call Transcript: Q1 2026
Solid Q1 performance with 4% organic revenue and 10% operating income growth, driven by margin expansion, FME25+ savings, and accelerated 5008X rollout. Outlook for 2026 remains stable, with inflation and regulatory risks closely monitored.
Fresenius Medical reports Q1 EPS ex-items EUR0.91 vs. EUR0.84 last year
Reports Q1 revenue EUR4.612B vs. EUR4.881B last year. “Fresenius Medical (FMS) Care delivered continued operational and financial progress in the Q1, with organic revenue growth, improved profitabilit...
Fresenius Medical sees FY26 revenue EUR19.628B
In 2026, Fresenius Medical (FMS) Care expects revenue growth to be broadly flat compared to prior year. The company expects operating income to remain on a consistent level, with a
Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed
Organic revenue growth1 of 4% with growth in all operating segments Operating income2 grew 10%, resulting in further margin expansion to 10.1% FME25+ transformation program related one-time costs main...
Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed
Organic revenue growth 1 of 4% with growth in all operating segments Operating income 2 grew 10%, resulting in further margin expansion to 10.1% FME25+ transformation program related one-time costs ma...
Palantir stark, ON Semi solide, Nebius im Höhenflug
In der heutigen Sendung geht es um diese Werte: Secunet Security Networks, CTS Eventim, Deutsche Post, Fresenius Medical Care, Norwegian Cruise Line, Berkshire Hathaway, Amazon, Duolingo, On Semicondu...
Fresenius Medical Care Posts Lower Net Profit on One-Off Costs
The dialysis specialist started restructuring its U.S. network by exiting 64 of up to 100 clinics.
Fresenius Medical Care's revenue falls in Q1 as weak dollar takes toll
Fresenius Medical Care said on Tuesday its revenue fell 6% in the first quarter of 2026, weighed down by significant currency effects, mainly from the weak U.S. dollar, and recent divestitures.
Fresenius Medical price target raised to EUR 40 from EUR 39.50 at Citi
Citi raised the firm’s price target on Fresenius Medical (FMS) to EUR 40 from EUR 39.50 and keeps a Neutral rating on the shares. Published first on TheFly – the
Humacyte realigns ex-U.S. rights to Symvess through Fresenius Medical pact
Humacyte (HUMA) announced that it has realigned the ex-U.S. rights to Symvess through an amendment to its distribution agreement with Fresenius Medical Care (FMS). “We are pleased to have worked
Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess
- Ex-U.S. rights realigned under amendment to distribution agreement with Fresenius Medical Care - - Positions Humacyte to advance discussions with corporate partners regarding international and indic...
Quest Diagnostics Q1 2026 Earnings Call: Complete Transcript
Quest Diagnostics (NYSE: DGX) released first-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings c...
EQS-CMS: Fresenius Medical Care AG : Release of a capital market information
EQS Post-admission Duties announcement: Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Fresenius Medical Care AG : Release of a capital marke...
Fresenius Medical price target lowered to EUR 42 from EUR 44 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Fresenius Medical (FMS) to EUR 42 from EUR 44 and keeps a Hold rating on the shares. Published first on TheFly –
Fresenius Medical price target lowered to EUR 34 from EUR 36 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Fresenius Medical (FMS) to EUR 34 from EUR 36 and keeps an Underweight rating on the shares. Published first on TheFly –
Fresenius Medical Care AG Earnings Call Transcript: Q4 2025
Delivered strong 2025 results with record profitability, robust cash flow, and margin expansion, supported by strategic initiatives and cost savings. 2026 is expected to be a transition year with flat earnings amid regulatory headwinds and major investments, but long-term growth and margin targets remain intact.
Fresenius Medical reports Q4 EPS ex-items EUR1.44 vs. EUR0.91 last year
Reports Q4 revenue EUR5.07B vs. EUR5.08B last year. “Fresenius Medical (FMS) Care closed a milestone year marked by outstanding profitability gains. Over the past three years, we built a stronger
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band
Strong organic revenue growth1 in 2025 of 8% driven by all operating segments Driven by an exceptional Q4, full year operating income2 growth of 27% reached top end of financial outlook, resulting in ...
Fresenius Medical Care Shares Drop After Outlook, U.S. Performance Underwhelms
Shares in the dialysis specialist were down 7.1% in European midday trade, with the decline erasing gains since the start of 2026.
Fresenius Medical Care AG Earnings Call Transcript: Q4 2025
Strong 2025 results with 8% organic revenue growth, 31% higher operating income, and 44% EPS growth. 2026 is a transition year with flat revenue expected, significant investment in U.S. HDF rollout, and continued focus on operational excellence and margin improvement.